MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes

Osteoarthritis and Cartilage

Volumn 21, Issue 7, 2013, Pages 981-989

  Park, S J ^a   Cheon, E J ^a   Kim, H A ^a  

^a Hallym University   (South Korea)

Author keywords

Chondrocytes; COX 2; IL 1 ; MiRNA 558; Osteoarthritis

Indexed keywords

COLLAGENASE 3; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; MESSENGER RNA; MICRORNA; MICRORNA 558; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; UNCLASSIFIED DRUG;

ARTICLE; CARTILAGE CELL; CATABOLISM; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARTILAGE, ARTICULAR; CASE-CONTROL STUDIES; CHONDROCYTES; CYCLOOXYGENASE 2; DINOPROSTONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERLEUKIN-1BETA; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 13; MICRORNAS; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; OSTEOARTHRITIS, KNEE; RNA, MESSENGER;

EID: 84879460516     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2013.04.012     Document Type: Article

References (44)

1. Sandell L.J., Aigner T. Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis. Arthritis Res. 2001, 3:107-113.
2. Loeuille D., Chary-Valckenaere I., Champigneulle J., Rat A.C., Toussaint F., Pinzano-Watrin A., et al. Macroscopic and microscopic features of synovial membrane inflammation in the osteoarthritic knee: correlating magnetic resonance imaging findings with disease severity. Arthritis Rheum 2005, 52:3492-3501.
3. Loeser R.F., Goldring S.R., Scanzello C.R., Goldring M.B. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum 2012, 64:1697-1707.
4. McDevitt C., Gilbertson E., Muir H. An experimental model of osteoarthritis; early morphological and biochemical changes. JBone Joint Surg Br 1977, 59:24-35.
5. Tanigawa S., Aida Y., Kawato T., Honda K., Nakayama G., Motohashi M., et al. Interleukin-17F affects cartilage matrix turnover by increasing the expression of collagenases and stromelysin-1 and by decreasing the expression of their inhibitors and extracellular matrix components in chondrocytes. Cytokine 2011, 56:376-386.
6. Kobayashi M., Squires G.R., Mousa A., Tanzer M., Zukor D.J., Antoniou J., et al. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. Arthritis Rheum 2005, 52:128-135.
7. Daheshia M., Yao J.Q. The interleukin 1 beta pathway in the pathogenesis of osteoarthritis. JRheumatol 2008, 35:2306-2312.
8. Goldring M.B. Osteoarthritis and cartilage: the role of cytokines. Curr Rheumatol Rep 2000, 2:459-465.
9. Martel-Pelletier J., Pelletier J.P., Fahmi H. Cyclooxygenase-2 and prostaglandins in articular tissues. Semin Arthritis Rheum 2003, 33:155-167.
10. Attur M., Al-Mussawir H.E., Patel J., Kitay A., Dave M., Palmer G., et al. Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor. JImmunol 2008, 181:5082-5088.
11. Hardy M.M., Seibert K., Manning P.T., Currie M.G., Woerner B.M., Edwards D., et al. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants. Arthritis Rheum 2002, 46:1789-1803.
12. Ding C. Do NSAIDs affect the progression of osteoarthritis?. Inflammation 2002, 26:139-142.
13. Engels B.M., Hutvagner G. Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene 2006, 25:6163-6169.
14. Hagen J., Lai E. microRNA control of cell-cell signaling during development and disease. Cell Cycle 2008, 7:2327.
15. Kloosterman W., Plasterk R. The diverse functions of microRNAs in animal development and disease. Dev Cell 2006, 11:441-450.
16. Swingler T.E., Wheeler G., Carmont V., Elliott H.R., Barter M.J., Abu-Elmagd M., et al. The expression and function of microRNAs in chondrogenesis and osteoarthritis. Arthritis Rheum 2012, 64:1909-1919.
17. Osman A. MicroRNAs in health and disease - basic science and clinical applications. Clin Lab 2012, 58:393-402.
18. Jones S.W., Watkins G., Le Good N., Roberts S., Murphy C.L., Brockbank S.M., et al. The identification of differentially expressed microRNAs in osteoarthritic tissue that modulate the production of TNF-α/MMP-13. Osteoarthritis Cartilage 2009, 17:464-472.
19. Kobayashi T., Lu J., Cobb B.S., Rodda S.J., McMahon A.P., Schipani E., et al. Dicer-dependent pathways regulate chondrocyte proliferation and differentiation. Proc Natl Acad Sci USA 2008, 105:1949-1954.
20. Miyaki S., Sato T., Inoue A., Otsuki S., Ito Y., Yokoyama S., et al. MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev 2010, 24:1173-1185.
21. Akhtar N., Rasheed Z., Ramamurthy S., Anbazhagan A.N., Voss F.R., Haqqi T.M. MicroRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes. Arthritis Rheum 2010, 62:1361-1371.
22. Cummins J.M., He Y., Leary R.J., Pagliarini R., Diaz L.A., Sjoblom T., et al. The colorectal microRNAome. Proc Natl Acad Sci USA 2006, 103:3687-3692.
23. Maes O.C., An J., Sarojini H., Wu H., Wang E. Changes in MicroRNA expression patterns in human fibroblasts after low-LET radiation. JCell Biochem 2008 Oct 15, 105:824-834.
24. Altman R., Alarcon G., Appelrouth D., Bloch D., Borenstein D., Brandt K., et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991, 34:505-514.
25. Alman R., Asch E., Bloch D., Bole G., Borenstein D., Brandt K., et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986, 29:1039-1049.
26. Tardif G., Hum D., Pelletier J.P., Duval N., Martel-Pelletier J. Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes. BMC Musculoskelet Disord 2009, 10:148.
27. Diaz-Prado S., Cicione C., Muiños-Lopez E., Hermida-Gomez T., Oreiro N., Fernandez-Lopez C., et al. Characterization of microRNA expression profiles in normal and osteoarthritic human chondrocytes. BMC Musculoskelet Disord 2012, 13:144.
28. Iliopoulos D., Malizos K.N., Oikonomou P., Tsezou A. Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS One 2008, 3:e3740.
29. * regulates the expression of cyclooxygenase-2 in human chondrocytes. Ann Rheum Dis 2012, 71:1073-1080.
30. Miyaki S., Nakasa T., Otsuki S., Grogan S.P., Higashiyama R., Inoue A., et al. MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis Rheum 2009, 60:2723-2730.
31. John B., Enright A.J., Aravin A., Tuschl T., Sander C., Marks D.S. Human MicroRNA targets. PLoS Biol 2004, 2:e363.
32. Betel D., Wilson M., Gabow A., Marks D.S., Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res 2008, 36:D149-D153.
33. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
34. Grimson A., Farh K.K., Johnston W.K., Garrett-Engele P., Lim L.P., Bartel D.P. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 2007, 27:91-105.
35. Friedman R.C., Farh K.K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009, 19:92-105.
36. Krek A., Grün D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., et al. Combinatorial microRNA target predictions. Nat Genet 2005, 37:495-500.
37. Lall S., Grün D., Krek A., Chen K., Wang Y.L., Dewey C.N., et al. Agenome-wide map of conserved microRNA targets in C. elegans. Curr Biol 2006, 16:460-471.
38. Baek D., Villen J., Shin C., Camargo F.D., Gygi S.P., Bartel D.P. The impact of microRNAs on protein output. Nature 2008, 455:64-71.
39. Selbach M., Schwanhausser B., Thierfelder N., Fang Z., Khanin R., Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455:58-63.
40. Sethupathy P., Megraw M., Hatzigeorgiou A.G. Aguide through present computational approaches for the identification of mammalian microRNA targets. Nat Methods 2006, 3:881-886.
41. Yu J.M., Wu X., Gimble J.M., Guan X., Freitas M.A., Bunnell B.A. Age-related changes in mesenchymal stem cells derived from rhesus macaque bone marrow. Aging Cell 2011, 10:66-79.
42. Shohet J.M., Ghosh R., Coarfa C., Ludwig A., Benham A.L., Chen Z., et al. Agenome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma. Cancer Res 2011, 71:3841-3851.
43. Murakami M., Kudo I. Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway. Prog Lipid Res 2004, 43:3-35.
44. Hoberg M., Aicher W.K., Wülker N., Rudert M. Expression analysis of different collagens and cytokines in cartilage cells derived from arthritic hip and knee joints. ZOrthop Ihre Grenzgeb 2006, 144:289-295.